PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 15519677-12 2004 The D2R blockade by sulpiride increased POMC mRNA levels in the hypothalamus, indicating that D2R exerts a tonic inhibitory effect on hypothalamic POMC gene expression. Sulpiride 20-29 proopiomelanocortin Rattus norvegicus 40-44 15519677-12 2004 The D2R blockade by sulpiride increased POMC mRNA levels in the hypothalamus, indicating that D2R exerts a tonic inhibitory effect on hypothalamic POMC gene expression. Sulpiride 20-29 proopiomelanocortin Rattus norvegicus 147-151 2540019-4 1989 Sulpiride, a D2-dopamine receptor antagonist, at a concentration of 10(-6) M, induced a significant (P less than 0.05) increase of both basal and potassium-stimulated alpha-MSH release to 203 +/- 21% and 447 +/- 88% of basal release in normal ACSF respectively. Sulpiride 0-9 proopiomelanocortin Rattus norvegicus 167-176 7518029-2 1994 In the pituitary, haloperidol and sulpiride induced similar increases of mRNAs of pro-opiomelanocortin (POMC) (+65% and +73%), prolactin (PRL) (+821% and +840%) and growth hormone (GH) (+32% and +47%), but sulpiride induced a greater increase of D2R mRNA (+125%) than haloperidol (+92%). Sulpiride 34-43 proopiomelanocortin Rattus norvegicus 82-102 7518029-2 1994 In the pituitary, haloperidol and sulpiride induced similar increases of mRNAs of pro-opiomelanocortin (POMC) (+65% and +73%), prolactin (PRL) (+821% and +840%) and growth hormone (GH) (+32% and +47%), but sulpiride induced a greater increase of D2R mRNA (+125%) than haloperidol (+92%). Sulpiride 34-43 proopiomelanocortin Rattus norvegicus 104-108 3979429-4 1985 The inhibitory effects of (+)3-PPP on both transmitter and alpha-MSH release were antagonized by the selective D-2 receptor antagonist (-)-sulpiride. Sulpiride 135-148 proopiomelanocortin Rattus norvegicus 59-68